Clinical Trials
12 trialsNCT03609840 2023-09-21
Study of Thiotepa and TEPA Drug Exposure in Pediatric Hematopoietic Stem Cell Transplant Patients
University of California, San Francisco
Completed
NCT05792891 2023-05-08
COMETA
Regina Elena Cancer Institute
Completed
NCT03374566 2023-02-09
Immunodeficiency for Severe Epstein-Barr Virus Infection
Children's Hospital of Fudan University
Completed
NCT01316549 2021-10-04
HCT
University of California, San Francisco
Completed
NCT03609814 2021-10-04
Study of Clofarabine and Fludarabine Drug Exposure in Pediatric Bone Marrow Transplantation (HCT)
University of California, San Francisco
Completed
NCT03609827 2021-10-04
Study of Melphalan Drug Exposure in Pediatric Hematopoietic Stem Cell Transplant Patients
University of California, San Francisco
Completed
NCT00553098 2020-02-17
Alemtuzumab, Fludarabine Phosphate, and Total-Body Irradiation Followed by a Donor Stem Cell Transplant in Treating Patients With Immunodeficiency or Other Nonmalignant Inherited Disorders
Fred Hutchinson Cancer Center
Phase 2 Completed
NCT01049854 2018-08-21
CD34+Selection for Partially Matched Family or Matched Unrelated Adult Donor Transplant
New York Medical College
Phase 2 Completed
NCT00517803 2017-08-28
Micronutrient Supplemented Probiotic Yogurt for HIV/AIDS and Other Immunodeficiencies
London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's
Phase NA Completed
NCT00179790 2017-03-06
Reduced Intensity Transplant Using Extracorporeal Photopheresis
Ann & Robert H Lurie Children's Hospital of Chicago
Phase 1/2 Completed
NCT00188292 2016-03-08
TRACE
University Health Network, Toronto
Completed
NCT01123590 2010-11-23
Characteristics of Patients With Thymoma in Chulalongkorn Hospital
Chulalongkorn University
Completed